10-1074-LS
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for 10-1074-LS, covering 2023-06-26 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: 3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803) [Phase 1]